The association between hydrochlorothiazide (HCTZ) and skin cancer remains controversial. A team of investigators from the Canadian Network for Observational Drug Effect Studies (CNODES) led by Dr. Laurent Azoulay and including Dr. Greg Carney of...
On September 5, 2019, British Columbia announced a new policy to switch from originator to biosimilar infliximab for patients with inflammatory bowel diseases (IBD). Subsequently, Dr. Anat Fisher and colleagues in the TI’s Pharmacoepidemiology Working...
The results of many clinical trials are not publicly reported, or reported only after a long delay. Why? Dr. Richard Morrow explored the views of trial participants, scientists, and administrators in a study performed for...
From the clinicians who brought you the highly acclaimed Best Science Medicine Course; Meds Conference; BS Medicine Podcast; Practical Evidence for Informed Practice (PEIP) Conference; and Tools for Practice comes the...